Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000202394 | SCV001567030 | uncertain significance | Combined oxidative phosphorylation defect type 27 | 2021-11-23 | criteria provided, single submitter | clinical testing | This sequence change replaces proline, which is neutral and non-polar, with leucine, which is neutral and non-polar, at codon 251 of the CARS2 protein (p.Pro251Leu). This variant is present in population databases (rs557671802, gnomAD 0.01%). This missense change has been observed in individual(s) with clinical features of a CARS2-related condition (PMID: 25787132). ClinVar contains an entry for this variant (Variation ID: 218178). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
OMIM | RCV000202394 | SCV000257435 | pathogenic | Combined oxidative phosphorylation defect type 27 | 2015-03-18 | no assertion criteria provided | literature only |